Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications
详细信息 查看全文
- 作者：Sellappan Selvamurugan ; Rangasamy Ramachandran ; Periasamy Viswanathamurthi
- 关键词：Ruthenium(II) complexes ; Spectral studies ; Antioxidant ; Anticancer activity ; DNA cleavage
- 刊名：Biometals
- 出版年：2013
- 出版时间：October 2013
- 年：2013
- 卷：26
- 期：5
- 页码：741-753
- 全文大小：782KB
- 参考文献：1. Alagesan M, Bhuvanesh SP, Dharmaraj N (2013) Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties. Dalton Trans 42:7210-223 CrossRef
2. Anitha P, Manikandan R, Endo A, Hashimoto T, Viswanathamurthi P (2012) Ruthenium(II) complexes containing quinone based ligands: Synthesis, characterization, catalytic applications and DNA interaction. Spectrochim Acta A 99:174-80 CrossRef
3. Atasever B, Ulkuseven B, Bal-Demirci T, Erdem-Kuruca S, Solako?lu Z (2010) Cytotoxic activities of new iron(III) and nickel(II) chelates of some / S-methyl-thiosemicarbazones on K562 and ECV304 cells. Invest New Drugs 28:421-32 CrossRef
4. Bal T, Atasever B, Solako?lu Z, Erdem-Kuruca S, Ulküseven B (2007) Synthesis, characterisation and cytotoxic properties of the N1, N4-diarylidene-S-methyl-thiosemicarbazone chelates with Fe(III) and Ni(II). Eur J Med Chem 42(2):161-67 CrossRef
5. Beckford FA, Leblanc G, Thessing J, Shaloski M, Frost BJ, Li L, Seeram NP (2009) Organometallic ruthenium complexes with thiosemicarbazone ligands: Synthesis, structure and cytotoxicity of [(η6- / p-cymene)Ru(NS)Cl]+ (NS?=?9-anthraldehyde thiosemicarbazones). Inorg Chem Commun 12:1094-098 CrossRef
6. Blagosklonny M, EI-diery WS (1996) In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug. Int J Cancer 67:386-92 CrossRef
7. Da S, Maia PI, Pavan FR, Leite CQF, Lemos SS, de Sousa GF, Batista AA, Nascimento OR, Ellena J, Castellano EE, Niquet E, Deflon VM (2009) Vanadium complexes with thiosemicarbazones: synthesis, characterization, crystal structures and anti- / Mycobacterium tuberculosis activity. Polyhedron 28:398-06 CrossRef
8. Demoro B, Sarniguet C, Sanchez-Delgado R, Rossi M, Liebowitz D, Caruso F, Olea-Azar C, Moreno V, Medeiros A, Comini MA, Otero L, Gambino D (2012) New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents. Dalton Trans 41(5):1534-543 CrossRef
9. Fricker SP (2007) Metal based drugs: from serendipity to design. Dalton Trans 43:4903-917 CrossRef
10. Fry NL, Mascharak PK (2011) Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light. Acc Chem Res 44:289-98 CrossRef
11. Gulcin I, Kufrevioglu OI, Oktay M, Buyukokuroglu ME (2004) Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle ( / Urtica dioica L.). J Ethnopharmacol 90:205-15 CrossRef
12. Hanson K, Wilger DJ, Jones ST, Harrison DP, Bettis SE, Luo H, Papanikolas JM, Waters ML, Meyer TJ (2013) Electron transfer dynamics of peptide-derivatized RuII-polypyridyl complexes on nanocrystalline metal oxide films. Pept Sci 100:25-7 CrossRef
13. Hartinger CG, Dyson PJ (2009) Bioorganometallic chemistry—from teaching paradigms to medicinal applications. Chem Soc Rev 38:391-01 CrossRef
14. Hsu CW, Kuo CF, Chuang SM, Hou MH (2013) Elucidation of the DNA-interacting properties and anticancer activity of a Ni (II)-coordinated mithramycin dimer complex. Biometals 26:1-2 CrossRef
15. Jouad EM, Thanh XD, Bouet G, Bonneau S, Khan MA (2002) In vitro and in vivo effects of [Ni(M5FTSC)2C12] complex in cancer: preliminary tests. Anticancer Res 22:1713
16. Kalaivani P, Prabhakaran R, Poornima P, Dallemer F, Vijayalakshmi K, Vijaya Padma V, Natarajan K (2012) Versatile coordination behavior of salicylaldehyde thiosemicarbazone in ruthenium(II) carbonyl complexes: synthesis, spectral, X-ray, electrochemistry, DNA binding, cytotoxicity, and cellular uptake Studies. Organometallics 31:8323-332 CrossRef
17. Ma ZY, Qiao X, Xie CZ, Shao J, Xu JY, Qiang ZY, Lou JS (2012) Activities of a novel Schiff base copper(II) complex on growth inhibition and apoptosis induction toward MCF-7 human breast cancer cells via mitochondrial pathway. J Inorg Biochem 117:1- CrossRef
18. Muthu Tamizh M, Mereiter K, Kirchner K, Karvembu K (2012) Ruthenium(II) carbonyl complexes containing pincer like ONS donor Schiff base and triphenylphosphine as catalyst for selective oxidation of alcohols at room temperature. J Organomet Chem 700:194-01 CrossRef
19. Narayana Prabhu R, Ramesh R (2012) Synthesis, structural characterization, electrochemistry and catalytic transfer hydrogenation of ruthenium(II) carbonyl complexes containing tridentate benzoylhydrazone ligands. J Organomet Chem 718:43-1 CrossRef
20. Nareshkumar K, Ramesh R (2005) Synthesis, luminescent, redox and catalytic properties of Ru(II) carbonyl complexes containing 2N2O donors. Polyhedron 24:1885-892 CrossRef
21. Pal S (2002) Ruthenium(II) complexes containing RuN4O2 spheres assembled via pyridine-imine-amide coordination. Syntheses, structures, properties and protonation behaviour of coordinated amide. J Chem Soc Dalton Trans. doi:10.1039/B110912J
22. Ramachandran R, Viswanathamurthi P (2013) Ruthenium(II) carbonyl complexes containing pyridine carboxamide ligands and PPh3/AsPh3/Py coligands: synthesis, spectral characterization, catalytic and antioxidant studies. Spectrochim Acta A 103:53-1 CrossRef
23. Ramachandran E, Thomas SP, Poornima P, Kalaivani P, Prabhakaran R, Vijaya Padma V, Natarajan K (2012) Evaluation of DNA binding, antioxidant and cytotoxic activity of mononuclear Co(III) complexes of 2-oxo-1,2-dihydrobenzo[ / h]quinoline-3-carbaldehyde thiosemicarbazones. Eur J Med Chem 50:405-15 CrossRef
24. Rice-Evans CA, Diplock AT (1993) Current status of antioxidant therapy. Free Radic Biol Med 15:77-6 CrossRef
25. Sathiya Kamatchi T, Chitrapriya N, Lee H, Fronczek CF, Fronczek FR, Natarajan K (2012) Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro. Dalton Trans 41:2066-077 CrossRef
26. Sathyadevi P, Krishnamoorthy P, Bhuvanesh SP, Kalaiselvi P, Vijaya Padma V, Dharmaraj N (2012) Organometallic ruthenium(II) complexes: Synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity. Eur J Med Chem 55:420-31 CrossRef
27. Senthil Raja D, Bhuvanesh SP, Natarajan K (2011) Biological evaluation of a novel water soluble sulphur bridged binuclear copper(II) thiosemicarbazone complex. Eur J Med Chem 46:4584-594 CrossRef
28. Stringer T, Therrien B, Hendricks DT, Guzgav H, Smith GS (2011) Mono- and di-nuclear (η6-arene) ruthenium(II) benzaldehyde thiosemicarbazone complexes: Synthesis, characterization and cytotoxicity. Inorg Chem Commun 14(6):956-60 CrossRef
29. Su W, Zhou Q, Huang Y, Huang Q, Huo L, Xiao Q, Huang S, Huang C, Chen R, Qian Q, Liu L, Li P (2013) Synthesis, crystal and electronic structure, anticancer activity of ruthenium(II) arene complexes with thiosemicarbazones. Appl Organomet Chem 27:307-12 CrossRef
30. Tsai K, Hsu TG, Hsu KM, Cheng H, Liu TY, Hsu CF, Kong CW (2001) Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radic Biol Med 31:1465-472 CrossRef
31. Udilova N, Kozlov AV, Bieberschulte W, Frei K, Ehrenberger K, Nohl H (2003) The antioxidant activity of caroverine. Biochem Pharmacol 65:59-5 CrossRef
32. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307-20 CrossRef
33. Wang BD, Yang ZY, Lu MH, Hai J, Wang Q, Chen ZN (2009) Synthesis, characterization, cytotoxic activity and DNA binding Ni(II) complex with the 6-hydroxy chromone-3-carbaldehyde thiosemicarbazone. J Organomet Chem 694:4069-075 CrossRef
34. Xie YY, Huang HL, Yao JH, Lin GJ, Jiang GB, Liu YJ (2013) DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes. Eur J Med Chem 63:603-10 CrossRef - 作者单位：Sellappan Selvamurugan (1)
Rangasamy Ramachandran (1)
Periasamy Viswanathamurthi (1)
1. Department of Chemistry, Periyar University, Salem, 636011, India - ISSN：1572-8773
文摘
A series of hexa-coordinated ruthenium(II) complexes of the type [Ru(CO)(B)L n ] (n?=?1-; B?=?PPh3, AsPh3 or Py) have been synthesized by reacting dibasic quadridentate Schiff base ligands H2L n (n?=?1-) with starting complexes [RuHCl(CO)(EPh3)2(B)] (E?=?P or As; B?=?PPh3, AsPh3 or Py). The synthesized complexes were characterized using elemental and various spectral studies including UV–Vis, FT-IR, NMR (1H, 13C and 31P) and mass spectroscopy. An octahedral geometry was tentatively proposed for all the complexes based on the spectral data obtained. The experiments on antioxidant activity showed that the ruthenium(II) S-methylisothiosemicarbazone Schiff base complexes exhibited good scavenging activity against various free radicals (DPPH, OH and NO). The in vitro cytotoxicity of these complexes has been evaluated by MTT assay. The results demonstrate that the complexes have good anticancer activities against selected cancer cell line, human breast cancer cell line (MCF-7) and human skin carcinoma cell line (A431). The DNA cleavage studies showed that the complexes have better cleavage of pBR 322 DNA.